½ÃÀ庸°í¼­
»óǰÄÚµå
1299770

°Ô³ð ÆíÁý ½ÃÀå : ¿ëµµº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)

Genome Editing Market with COVID-19 Impact Analysis, By Application, By Technology, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 300 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÁÖ¿ä ³»¿ë

°Ô³ð ÆíÁý ½ÃÀå ±Ô¸ð´Â 2022³â 50¾ï 8,070¸¸ ´Þ·¯·Î 2023³âºÎÅÍ 2030³â±îÁö CAGR 22.3%·Î È®´ë

°Ô³ð ÆíÁý ½ÃÀå - ½ÃÀå ¿ªÇÐ:

°Ô³ð ÆíÁýÀº Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¾Ï ¹× ±âŸ À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¤ºÎÀÇ ¼ºÀå ¹× ÀÚ±ÝÀÇ °¡¿ë¼ºÀº °Ô³ð ÆíÁý ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±×·¯³ª ±ÔÁ¦, °úÇÐÀû, À±¸®Àû À̽´´Â ³ôÀº Àåºñ ºñ¿ë°ú ÇÔ²² °Ô³ð ÆíÁý ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

¶ÇÇÑ, Àΰ£ À¯Àü¼º ÁúȯÀÇ °ü¸® ¹× ½Äº°, ½Å¾à °³¹ßÀº °Ô³ð ÆíÁý ½ÃÀå¿¡ Å« ±âȸ°¡ µÉ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ÇÁ·ÎÆÄÀϸµ, DNA ºÐ¼®, NGS, µ¿½Ä¹° À¯Àü°øÇп¡´Â °Ô³ð ÆíÁýÀÌ ÇÊ¿äÇÕ´Ï´Ù. µû¶ó¼­ °Ô³ð ÆíÁýÀÇ ÀÀ¿ë ºÐ¾ß°¡ Áõ°¡ÇÔ¿¡ µû¶ó °Ô³ð ÆíÁý¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. COVID-19ÀÇ ´ëÀ¯ÇàÀº °Ô³ð ÆíÁý ½ÃÀå ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, COVID-19ÀÇ ´ëÀ¯ÇàÀº Àü ¼¼°èÀûÀ¸·Î ÇコÄÉ¾î ºÐ¾ßÀÇ ¿öÅ©Ç÷ο츦 È¥¶õ¿¡ ºü¶ß·È½À´Ï´Ù. Áúº´ÀÇ È®»êÀ¸·Î ÀÎÇØ »ê¾÷ÀÌ ÀϽÃÀûÀ¸·Î Æó¼âµÇ¾ú°í, ±× °á°ú Àü¿°º´ ±â°£ µ¿¾È °Ô³ð ÆíÁý¿¡ ´ëÇÑ ¼ö¿ä°¡ °¨¼ÒÇß½À´Ï´Ù.

°Ô³ð ÆíÁý ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

¼¼°è °Ô³ð ÆíÁý ½ÃÀåÀº ¿ëµµ, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

¼¼Æ÷ÁÖ°øÇÐ, À¯Àü°øÇÐ, ½Å¾à°³¹ß, À¯ÀüÀÚº¯Çü¼¼Æ÷Ä¡·á, Áø´Ü, ±âŸ µîÀÔ´Ï´Ù. ¼¼Æ÷ÁÖ °øÇÐ ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â Áٱ⼼Æ÷¸¦ ÀÌ¿ëÇÑ ¿¬±¸¿¡¼­ ¼¼Æ÷ÁÖ °øÇÐÀÇ È°¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

½ÃÀåÀº ±â¼ú¿¡ µû¶ó CRISPR, TALEN, ZFN, ±âŸ µî ¼¼ °¡Áö ¹üÁÖ·Î ³ª´µ´Âµ¥, CRISPR ºÐ¾ß°¡ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â¼úÀº CRISPRÀÇ ±â¼úÀû ¿ìÀ§·Î ÀÎÇØ °Ô³ð Á¶ÀÛ ºÐ¾ß¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ±× ÀåÁ¡Àº Á¦¾î, °¡À̵å RNA ƯÀÌÀû ȸ¼ö, Ç¥Àû À¯ÀüÀÚ ÆÄ±« µîÀÔ´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó ÇÐ°è ¹× Á¤ºÎ ±â°ü, »ý¸í°øÇÐ ¹× Á¦¾à ±â¾÷, °è¾à ¿¬±¸ ±â°üÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. »ý¸í°øÇÐ ¹× Á¦¾àȸ»ç ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Ï°ú °¨¿°¼º ÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ¿¬±¸ Ȱµ¿ÀÌ È°¹ßÇØÁö°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°Ô³ð ÆíÁý ½ÃÀå - °æÀï ±¸µµ:

½ÃÀåÀÇ °æÀï»çµéÀº ºñÁö´Ï½º °üÇà, º¸¾È ¿ä±¸, º¯È­ÇÏ´Â ±â¼ú¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ Á¦Ç°À» Á¦°øÇØ¾ß ÇÏ´Â °úÁ¦¸¦ ¾È°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀå ÁøÀÔ ±â¾÷µéÀº ºü¸¥ Á¢±Ù¼ºÀ» È®º¸Çϱâ À§ÇØ ±â¼ú ¿ª·®À» °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀº ¼¼°è ½ÃÀå¿¡¼­ ¹ßÆÇÀ» ¸¶·ÃÇϱâ À§ÇØ ÆÄÆ®³Ê½Ê, ÀμöÇÕº´, Á¦ÈÞ, ½ÅÁ¦Ç° Ãâ½Ã, R&D ºñ¿ë µî ´Ù¾çÇÑ Àü·«À» äÅÃÇÏ´Â µ¥ ²÷ÀÓ¾øÀÌ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 2¿ù ÀÎÅÚ¸®¾Æ¿Í ¸®Á¦³×·ÐÀº NTLA-2001ÀÇ ´Üȸ Åõ¿©¸¦ ÀÔÁõÇÏ´Â 1»ó µ¥ÀÌÅÍ ¾÷µ¥ÀÌÆ®¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ, Æ®·£½º½Ç·¹Æ¾(ATTR) ¾Æ¹Ð·ÎÀ̵åÁõ¿¡ ´ëÇÑ CRISPR Ä¡·á´Â ºü¸¥ °á°ú¸¦ °¡Á®¿Í Áúº´À» À¯¹ßÇÏ´Â ´Ü¹éÁúÀ» Áö¼ÓÀûÀÌ°í ±í°Ô °¨¼Ò½Ãŵ´Ï´Ù.

¿¬±¸ÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ °Ô³ð ÆíÁý ½ÃÀå Á¶»ç º¸°í¼­´Â 2022³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ½ÃÀå ±Ô¸ð, CAGR, ÃßÁ¤ ¹× ¿¹Ãø(2023-2030³â)À» Á¦°øÇÕ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â ´Ù¾çÇÑ ºÎ¹®/±¹°¡¿¡ °ÉÃÄ ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °Ô³ð ÆíÁý ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â Àüü º¸°í¼­¿¡¼­ »õ·Î¿î ÅõÀÚ ±âȸ, ±âÁ¸ ±â¾÷ÀÌ Á÷¸éÇÑ °úÁ¦, °Ô³ð ÆíÁý ½ÃÀå¿¡¼­ Áö¼Ó°¡´ÉÇÑ ¼ºÀå ¿äÀÎÀ» ÆÄ¾ÇÇß½À´Ï´Ù.

COVID-19°¡ °Ô³ð ÆíÁý ½ÃÀå ±Ô¸ð, ¿¹Ãø, CAGR, ½ÃÀå ¿ªÇп¡ ¹ÌÄ¡´Â ¿µÇâÀº ¿¬±¸ ¹üÀ§¿¡¼­ ÀÚ¼¼È÷ ³íÀǵǸç, COVID ÀÌÈÄ °Ô³ð ÆíÁý ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®µµ ´Ù·ì´Ï´Ù.

ÀÌ º¸°í¼­´Â »ç¿ëÀÚ¿¡°Ô °Ô³ð ÆíÁý ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °üÁ¡À» Á¦°øÇϱâ À§ÇØ °Ô³ð ÆíÁý ½ÃÀåÀÇ °æÀï »óȲ°ú ÁÖ¿ä Çõ½Å°¡ ºÐ¼®µµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ¿¬±¸´Â ½ÃÀå ±Ô¸ð, ¼ºÀå·ü, ¸Å·Âµµ¸¦ ±âÁØÀ¸·Î ¸ðµç »ê¾÷ ºÎ¹®À» º¥Ä¡¸¶Å·ÇÑ ¼ºÀå Àü¸Á ¸ÅÇÎ ºÐ¼®À» Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷ÀÇ »ó¼¼ÇÑ ±â¾÷ °³¿ä¸¦ ÅëÇØ °Ô³ð ÆíÁý ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ±â¾÷ÀÇ À繫 Á¤º¸ ¹× Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÀÌ º¸°í¼­´Â ¼¼°è»Ó¸¸ ¾Æ´Ï¶ó Áö¿ªÀû Â÷¿ø¿¡¼­µµ ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀÇ Áß¿äÇÑ ÀμöÇÕº´, Á¦ÈÞ ¹× ÇÕÀÛÅõÀÚ, ½ÅÁ¦Ç° Ãâ½Ã, ¿¬±¸°³¹ß, Áö¿ªÀû ÁøÃâ µîÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖµµ·Ï Çß½À´Ï´Ù.

¼¼°è °Ô³ð ÆíÁý ½ÃÀå º¸°í¼­´Â ÁÖ·Î °ø±Þ ¾÷ü, ÅõÀÚÀÚ, ½Å±Ô ÁøÀÔÀÚ, À¯Åë ¾÷ü, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °Ô³ð ÆíÁý ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ³»¿ª
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå °Ô³ð ÆíÁý ÁÖ¿ä ½ÃÀå µ¿Çâ

  • °Ô³ð ÆíÁý ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • °Ô³ð ÆíÁý ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • °Ô³ð ÆíÁý ½ÃÀåÀÇ ±âȸ
  • °Ô³ð ÆíÁý ½ÃÀå ÇâÈÄ µ¿Çâ

Á¦4Àå °Ô³ð ÆíÁý »ê¾÷ Á¶»ç

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ±ÔÁ¦ ü°è ºÐ¼®

Á¦5Àå °Ô³ð ÆíÁý ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå °Ô³ð ÆíÁý ½ÃÀå »óȲ

  • °Ô³ð ÆíÁý ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ³»¿ª µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ ºÐ¼®
    • ½ÅÈï ±â¾÷ ºÐ¼®

Á¦7Àå °Ô³ð ÆíÁý ½ÃÀå - ¿ëµµº°

  • °³¿ä
    • ¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ¼¼Æ÷ÁÖ °øÇÐ
    • À¯ÀüÀÚ °øÇÐ
    • Drug Discovery
    • À¯ÀüÀÚ º¯Çü ¼¼Æ÷ Ä¡·á¿Í Áø´Ü
    • ±âŸ

Á¦8Àå °Ô³ð ÆíÁý ½ÃÀå - ±â¼úº°

  • °³¿ä
    • ±â¼úº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • CRISPR
    • TALEN
    • ZFN
    • ±âŸ

Á¦9Àå °Ô³ð ÆíÁý ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
    • ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • Çмú±â°ü ¹× Á¤ºÎ±â°ü
    • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¹× Á¦¾àȸ»ç
    • ¼öŹÁ¶»ç±â°ü

Á¦10Àå °Ô³ð ÆíÁý ½ÃÀå - Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ °Ô³ð ÆíÁý ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ °Ô³ð ÆíÁý ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °Ô³ð ÆíÁý ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °Ô³ð ÆíÁý ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °Ô³ð ÆíÁý ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - °Ô³ð ÆíÁý »ê¾÷

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä
    • Precision Biosciences
    • BioMed Central Ltd
    • Aevi Genomic Medicine, Inc.
    • Deep Genomics
    • Editas Medicine
    • GenScript
    • Merck KGaA
    • Sangamo Therapeutics
    • Tecan Trading AG
    • CRISPR Therapeutics
    • Congenica Ltd.
    • Lonza
    • Cellectis SA

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§Àû Àü¸Á

ksm 23.08.17

REPORT HIGHLIGHT

Genome editing market size was valued at USD 5,080.7 Million in 2022, expanding at a CAGR of 22.3% from 2023 to 2030.

Genome editing is referring a technique for precise alterations to change the DNA of an organism. Additionally, it uses a unique enzyme known as an "engineered nuclease" in the genome that makes a precise cut. Moreover, a particular region of the DNA is cut, and the cell heals the damage automatically. It is utilized in several fields such as biotechnology, mutation, agriculture, and medicines. Further, by altering human blood cells they are then injected into the body to treat several diseases including cancer, AIDS, and cystic fibrosis.

Genome Editing Market- Market Dynamics:

In genome editing, continuous technological advancements are a major factor expected to propel market growth. Additionally, the increasing prevalence of cancer & other genetic disorders and the availability of government growth & funding is attributed to driving the market growth of genome editing. However, regulatory, scientific, & ethical challenges along with high equipment costs will likely obstruct the genome editing market growth.

Moreover, the management & identification of human genetic illnesses and the development of new drugs are great opportunities for the genome editing market. Furthermore, profiling, DNA analysis, NGS, and genetic engineering of animals & plants need genome editing. Thereby, with rising application areas of genomics, the global demand for genome editing is anticipated to increase. The COVID-19 pandemic negatively impacted the market growth of genome editing. The COVID-19 outbreak has disrupted workflow globally In the healthcare sector. Due to the spread of disease industries shut their doors temporarily this in turn decreased the demand for genome editing during the pandemic.

Genome Editing Market- Segmentation Analysis:

The global genome editing market is segmented on the basis of application, technology, end-user, and region.

The market is divided into five categories based on application: cell line engineering, genetic engineering, drug discovery, gene-modified cell therapy, diagnostics, and others. The cell line engineering sector is expected to hold the largest market share. The growth can be attributed to the rising utilization of cell line engineering in stem cell-based research.

The market is divided into three categories based on technology: CRISPR, TALEN, ZFN, and others. The CRISPR sector is likely to maintain its dominance. The technique has revolutionized the genome manipulation space with CRISPR technical advantages. The advantages include regulation, guide RNA-specific recovery, and targeted gene disruption.

The market is divided into three categories based on end-user: academics & government institutes, biotechnology & pharma companies, and contract research organizations. The biotechnology & pharma companies sector is expected to possess the market. The rising prevalence of cancer and infectious diseases increasing research activities globally and this in turn expected to increase the segment growth.

Genome Editing Market-Competitive Landscape:

The market competitors are challenged to offer innovative offerings that enable communication in addressing business practices, security needs, and changing technologies. Additionally, to gain quick access market players are enhancing technological capabilities. Moreover, key players are constantly focusing to adopt various strategies such as partnerships, mergers & acquisitions, collaborations, new product launches, and R&D spending to gain a foothold in the global market. For instance, in February 2022, Intellia and Regeneron announced Updated Phase 1 Data Demonstrating a Single Dose of NTLA-2001. Additionally, it is an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis that give rapid result, Sustained and Deep Reduction in Disease-Causing Protein

Key features of the study:

This proposed research study on genome editing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for genome editing market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the genome editing market.

Impact of COVID-19 on genome editing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on genome editing market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the genome editing market, we have also included competitive landscape and key innovator analysis for the genome editing market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the genome editing market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global genome editing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOME EDITING MARKET KEY PLAYERS

  • Precision Biosciences
  • BioMed Central Ltd
  • Aevi Genomic Medicine, Inc.
  • Deep Genomics
  • Editas Medicine
  • GenScript
  • Merck KGaA
  • Sangamo Therapeutics
  • Tecan Trading AG
  • CRISPR Therapeutics
  • Congenica Ltd.
  • Lonza
  • Cellectis S.A

GLOBAL GENOME EDITING MARKET, BY APPLICATION

  • Cell line engineering
  • Genetic Engineering
  • Drug Discovery
  • Gene-modified cell therapy and Diagnostics
  • Others

GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY

  • CRISPR
  • TALEN
  • ZFN
  • Others

GLOBAL GENOME EDITING MARKET, BY END-USER

  • Academics & Government Institutes
  • Biotechnology & Pharma Companies
  • Contract Research Organizations

GLOBAL GENOME EDITING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genome Editing Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genome Editing Market Snippet by Application
    • 2.1.2. Genome Editing Market Snippet by Technology
    • 2.1.3. Genome Editing Market Snippet by End-User
    • 2.1.4. Genome Editing Market Snippet by Country
    • 2.1.5. Genome Editing Market Snippet by Region
  • 2.2. Competitive Insights

3. Genome Editing Key Market Trends

  • 3.1. Genome Editing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genome Editing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genome Editing Market Opportunities
  • 3.4. Genome Editing Market Future Trends

4. Genome Editing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genome Editing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genome Editing Market Landscape

  • 6.1. Genome Editing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genome Editing Market - By Application

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 7.1.2. Cell line engineering
    • 7.1.3. Genetic Engineering
    • 7.1.4. Drug Discovery
    • 7.1.5. Gene-modified cell therapy and Diagnostics
    • 7.1.6. Others

8. Genome Editing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2022&2030 (%)
    • 8.1.2. CRISPR
    • 8.1.3. TALEN
    • 8.1.4. ZFN
    • 8.1.5. Others

9. Genome Editing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022&2030 (%)
    • 9.1.2. Academics & Government Institutes
    • 9.1.3. Biotechnology & Pharma Companies
    • 9.1.4. Contract Research Organizations

10. Genome Editing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Genome Editing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Genome Editing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Genome Editing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Genome Editing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Genome Editing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Genome Editing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Precision Biosciences
    • 11.2.2. BioMed Central Ltd
    • 11.2.3. Aevi Genomic Medicine, Inc.
    • 11.2.4. Deep Genomics
    • 11.2.5. Editas Medicine
    • 11.2.6. GenScript
    • 11.2.7. Merck KGaA
    • 11.2.8. Sangamo Therapeutics
    • 11.2.9. Tecan Trading AG
    • 11.2.10. CRISPR Therapeutics
    • 11.2.11. Congenica Ltd.
    • 11.2.12. Lonza
    • 11.2.13. Cellectis S.A

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦